Casdin Capital, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Casdin Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $1.55 Million - $2.44 Million	1,459,747 New	1,459,747 $1.69 Million
Q2 2022 Aug 15, 2022	SELL	$2.2 - $4.2 $9.25 Million - $17.7 Million	-4,202,808 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.83 - $8.69 $356,814 - $1.1 Million	-126,083 Reduced 2.91%	4,202,808 $16.9 Million
Q4 2021 Feb 14, 2022	SELL	$8.31 - $14.92 $23.9 Million - $42.9 Million	-2,873,917 Reduced 39.9%	4,328,891 $36 Million
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $65.9 Million - $95.7 Million	7,202,808 New	7,202,808 $83.5 Million

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.